Topper James N Insider Trades

Insider Trading History

Track insider trading activity for Topper James N. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
10% owner
Holding Value $736k 66,718 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 24,122 shares
$11.40
$11.04
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,028,524 shares
Last Trade
Sep 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.6k 660 shares
$23.70
$33.29
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.4M 3,028,524 shares
Last Trade
Sep 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.38k 660 shares
$12.69
$24.89
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.4M 3,027,864 shares
Last Trade
Sep 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17k 1,260 shares
$13.52
$24.89
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,027,864 shares
Last Trade
Sep 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.5k 1,260 shares
$24.99
$33.29
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.3M 3,026,604 shares
Last Trade
Aug 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.21k 471 shares
$13.18
$24.89
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,026,604 shares
Last Trade
Aug 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.3k 471 shares
$23.98
$33.29
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,026,133 shares
Last Trade
Jun 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23k 1,260 shares
$18.26
$33.29
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.3M 3,026,133 shares
Last Trade
Jun 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.6k 1,260 shares
$9.17
$24.89
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.3M 3,024,873 shares
Last Trade
Jun 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.8k 2,520 shares
$9.43
$24.89
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,024,873 shares
Last Trade
Jun 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.4k 2,520 shares
$18.43
$33.29
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $101M 3,022,153 shares
Last Trade
Jun 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$167k 8,584 shares
$19.50
$33.29
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $75.2M 3,022,153 shares
Last Trade
Jun 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$81.9k 8,584 shares
$9.54
$24.89
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
10% owner
Holding Value $470k 42,596 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.6k 17,500 shares
$4.95
$11.04
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $656k 59,403 shares
Last Trade
May 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.6k 3,780 shares
$3.86
$11.04
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $614k 55,623 shares
Last Trade
May 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.9k 6,300 shares
$3.32
$11.04
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $544k 49,323 shares
Last Trade
May 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.54k 1,120 shares
$3.16
$11.04
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $532k 48,203 shares
Last Trade
May 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.3k 12,601 shares
$3.04
$11.04
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $393k 35,602 shares
Last Trade
May 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$115k 35,602 shares
$3.22
$11.04
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $100M 3,013,569 shares
Last Trade
Mar 26, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.5k 1,135 shares
$22.49
$33.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up